S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
NYSEARCA:XMAR

FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March (XMAR) Price, Holdings, & News

$32.94
-0.11 (-0.33%)
(As of 04/19/2024 08:51 PM ET)
Today's Range
$32.89
$33.02
50-Day Range
$32.94
$33.62
52-Week Range
$30.25
$33.74
Volume
53,300 shs
Average Volume
55,821 shs
Market Capitalization
$176.23 million
Assets Under Management
$17.87 million
Dividend Yield
N/A
Net Expense Ratio
0.00%

About FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March

The FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March (XMAR) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to outperform the SPY ETF at about 2x positive price returns while aiming for specific buffered losses and capped gains over a specific holdings period. The actively managed fund holds options and collateral. XMAR was launched on Mar 17, 2023 and is managed by First Trust.

XMAR Stock Price History

XMAR ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive XMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Fund Name
FT CBOE VST US EQ ENH MOD
Tax Classification
Current Symbol
NYSEARCA:XMAR
Inception Date
1/1/2100
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
0

Fund Statistics

Assets Under Management
$17.87 million
Average Daily Volume
$0.00
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
0.23
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March Expenses

TypeXMARNYSEARCA ETFsAll ETFs
Management Fee0.00%0.50%0.51%
Other Expenses0.00%0.64%0.58%
Total Expense0.00%0.74%0.70%
Fee Waiver0.00%-0.68%-0.57%
Net Expense0.00%0.57%0.58%

FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March (XMAR) Holdings

Top 6 XMAR Holdings

  • Option on SPDR® S&P 500 ETF Trust Mar25
    Holding Weight: 98.94%
  • Option on SPDR® S&P 500 ETF Trust Mar25
    Holding Weight: 9.28%
  • Option on SPDR® S&P 500 ETF Trust Mar25
    Holding Weight: 3.99%
  • Dreyfus Govt Cm Inst 289
    Holding Weight: 1.04%
  • Option on SPDR® S&P 500 ETF Trust Mar25
    Holding Weight: -1.53%
  • Option on SPDR® S&P 500 ETF Trust Mar25
    Holding Weight: -11.72%

XMAR ETF - Frequently Asked Questions

How have XMAR shares performed in 2024?

FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March's stock was trading at $32.88 at the beginning of 2024. Since then, XMAR stock has increased by 0.2% and is now trading at $32.94.
View the best growth stocks for 2024 here
.

How do I buy shares of FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - March?

Shares of XMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:XMAR) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners